Nitric oxide synthases: Structure, function and inhibition

Biochemical Journal

Volumn 357, Issue 3, 2001, Pages 593-615

  Alderton, W K ^a   Cooper, C E ^a   Knowles, R G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cofactor; Free radical; Haem enzyme; Inhibitor; Pterin

Indexed keywords

CRYSTAL STRUCTURE; ENZYME INHIBITION; FLAMMABILITY; IRON; STRUCTURE (COMPOSITION);

GENE TRANSCRIPTION;

NITRIC ACID;

AMINOGUANIDINE; ARGININE; BIOPTERIN; FREE RADICAL; HEAT SHOCK PROTEIN 90; HEME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGENASE; PROTOPORPHYRIN; PTERIN;

ALLOSTERISM; AMINO ACID SEQUENCE; BINDING SITE; COVALENT BOND; CRYSTAL STRUCTURE; DIMERIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME STRUCTURE; GENETIC TRANSCRIPTION; INFLAMMATION; NEGATIVE FEEDBACK; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN QUATERNARY STRUCTURE; REVIEW; STOICHIOMETRY;

ALTERNATIVE SPLICING; ANIMALS; CATALYSIS; DIMERIZATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MODELS, MOLECULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN STRUCTURE, TERTIARY;

EID: 0035425503     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3570593     Document Type: Review

References (231)

1. Citation superstars of the UK
2. Nitric oxide synthases in mammals
3. Nitric oxide synthase: Aspects concerning structure and catalysis
4. Nitric oxide synthases: Roles, tolls, and controls
5. Nitric oxide part B physiological pathological processes
6. Nitric oxide part A sources and detection of NO: NO synthase
7. Nitric oxide protocols
8. The L-arginine-nitric oxide pathway
9. Inducible nitric oxide synthase in human diseases
10. Inhibition of nitric oxide synthase as a potential therapeutic target
11. Nitric oxide. V. Therapeutic potential of nitric oxide donors and inhibitors
12. The use of nitric oxide donors in pharmacological studies
13. Bacterial nitric oxide synthesis
14. Nitric oxide in bacteria: Synthesis and consumption
15. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions
16. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle
17. Structural organization of the human neuronal nitric oxide synthase gene (NOS1)
18. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes
19. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line
20. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte
21. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase
22. Molecular cloning and characterization of human endothelial nitric oxide synthase
23. Prokaryotic expression of the heme- and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: Identification of the heme-binding proximal thiolate ligand as cysteine-415
24. Characterization of neuronal nitric oxide synthase and a C415H mutant, purified from a baculovirus overexpression system
25. Macrophage NO synthase: Characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction
26. Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase
27. Identification of the domains of neuronal nitric oxide synthase by limited proteolysis
28. Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system
29. Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthase
30. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes
31. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate
32. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation
33. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase
34. Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center
35. Cysteine-200 of human inducible nitric oxide synthase is essential for dimerization of haem domains and for binding of haem, nitroarginine and tetrahydrobiopterin
36. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers
37. Mutagenesis of acidic residues in the oxygenase domain of inducible nitric-oxide synthase identifies a glutamate involved in arginine binding
38. Structures of the N(omega)-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins
39. Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase
40. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity
41. Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase
42. No news is not necessarily good
43. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas
44. N-terminal domain swapping and metal ion binding in nitric oxide synthase dimerization
45. Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms
46. Structural variations on a theme of nitric oxide production by three isoforms of nitric oxide synthase
47. Mammalian nitric oxide synthases
48. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase
49. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer
50. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer
51. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry
52. Nomega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine
53. No NO from NO synthase
54. Formation of free nitric oxide from L-arginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase
55. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase
56. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide
57. Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production
58. Direct measurement of nitric oxide generation from nitric oxide synthase
59. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase
60. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
61. Electronparamagnetic resonance spectroscopy using N-methyl-D-glucamine dithiocarbamate iron cannot discriminate between nitric oxide and nitroxyl: Implications for the detection of reaction products for nitric oxide synthase
62. Hydrogen peroxide-supported oxidation of NG-hydroxy-L-arginine by nitric oxide synthase
63. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: Tetrahydrobiopterin binding kinetics and role of haem in dimerization
64. Origin of superoxide production by endothelial nitric oxide synthase
65. Inducible nitric-oxide synthase generates superoxide from the reductase domain
66. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
67. Reactions of nitric oxide with mitochondrial cytochrome c: A novel mechanism for the formation of nitroxyl anion and peroxynitrite
68. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide
69. The cytotoxicity of nitroxyl: Possible implications for the pathophysiological role of NO
70. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury
71. Nitric oxide synthases: Targets for therapeutic strategies in neurological diseases
72. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase
73. Role of reductase domain cluster 1 acidic residues in neuronal nitric-oxide synthase. Characterization of the FMN-free enzyme
74. Calmodulin activates intramolecular electron transfer between the two flavins of neuronal nitric oxide synthase flavin domain
75. Potentiometric analysis of the flavin cotactors of neuronal nitric oxide synthase
76. Heme iron reduction and catalysis by a nitric oxide synthase heterodimer containing one reductase and two oxygenase domains
77. Generation of superoxide by purified brain nitric oxide synthase
78. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein
79. Purification and characterization of a human NO synthase
80. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme
81. Oligomerization of endothelial nitric oxide synthase. Evidence for a dominant negative effect of truncation mutants
82. Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine
83. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain
84. Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay
85. Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction
86. Heme coordination and structure of the catalytic site in nitric oxide synthase
87. Tetrahydrobiopterin-deficient nitric oxide synthase has a modified heme environment and forms a cytochrome P-420 analogue
88. Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase
89. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. Evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin
90. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen
91. Reactivity of tetrahydrobiopterin bound to nitric-oxide synthase
92. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis and subunit dimerization in inducible nitric oxide synthase
93. The phenylalanine hydroxylating system
94. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: Heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin
95. Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin
96. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis and subunit dimerization in inducible nitric oxide synthase
97. Heme-containing oxygenases
98. Heme-mediated oxygen activation in biology: Cytochrome c oxidase and nitric oxide synthase
99. Nitric oxide: Physiological roles, biosynthesis and medical uses
100. Nitric oxide synthases: Properties and catalytic mechanism
101. Nitric oxide: A new paradigm for second messengers
102. Comparative effects of substrates and pterin cofactor on the heme midpoint potential in inducible and neuronal nitric oxide synthases
103. The ferrousdioxy complex of neuronal nitric oxide synthase. Divergent effects of L-arginine and tetrahydrobiopterin on its stability
104. Formation and reactions of the hemedioxygen intermediate in the first and second steps of nitric oxide synthesis as studied by stopped-flow spectroscopy under single-turnover conditions
105. On the mechanism of the nitric oxide synthase-catalyzed conversion of Nomega-hydroxyl-L-arginine to citrulline and nitric oxide
106. Formation of N delta-cyanoornithine from NG-hydroxy-L-arginine and hydrogen peroxide by neuronal nitric oxide synthase: Implications for mechanism
107. Nitric oxide and iron proteins
108. Nitric oxide complexes of inducible nitric oxide synthase: Spectral characterization and effect on catalytic activity
109. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis
110. A kinetic simulation model that describes catalysis and regulation in nitric-oxide synthase
111. Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension
112. Tryptophan 409 controls the activity of neuronal nitric-oxide synthase by regulating nitric oxide feedback inhibition
113. Molecular biology of nitric oxide synthases
114. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III)
115. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme
116. Characterization of the reductase domain of rat neuronal nitric oxide synthase generated in the methylotrophic yeast Pichia pastoris. Calmodulin response is complete within the reductase domain itself
117. Neuronal nitric-oxide synthase interaction with calmodulin-troponin C chimeras
118. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. Activation of intra- and interdomain electron transfer
119. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase
120. Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element
121. The 42-amino acid insert in the FMN domain of neuronal nitric-oxide synthase exerts control over Ca(2+)/calmodulin-dependent electron transfer
122. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress
123. Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress
124. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
125. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
126. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation
127. Inhibition of neuronal nitric-oxide synthase by calcium/calmodulin-dependent protein kinase IIalpha through Ser847 phosphorylation in NG1O8-NG115 neuronal cells
128. Regulation of neuronal nitric-oxide synthase by calmodulin kinases
129. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase
130. PIN: An associated protein inhibitor of neuronal nitric oxide synthase
131. Protein inhibitor of neuronal nitric-oxide synthase, PIN, binds to a 17-amino acid residue fragment of the enzyme
132. Binding of dynein light chain (PIN) to neuronal nitric oxide synthase in the absence of inhibition
133. The protein inhibitor of neuronal nitric oxide synthase (PIN): Characterization of its action on pure nitric oxide synthases
134. Brain cytoplasmic and flagellar outer arm dyneins share a highly conserved Mr 8,000 light chain
135. Dynamic activation of endothelial nitric oxide synthase by Hsp90
136. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton
137. Neuronal nitric-oxide synthase is regulated by the Hsp90-based chaperone system in vivo
138. Kalirin inhibition of inducible nitric-oxide synthase
139. Targeting and translocation of endothelial nitric oxide synthase
140. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: Mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoyladon-induced translocation of the enzyme
141. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: A green fluorescent protein study
142. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae
143. Receptor-regulated translocation of endothelial nitric-oxide synthase
144. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling
145. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells
146. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity
147. 2+-calmodulin and cavelin
148. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo
149. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis
150. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain
151. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains
152. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain
153. The neuronal nitric oxide synthase PDZ motif binds to -G(D,E)XV* carboxyterminal sequences
154. PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences
155. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase
156. Targeted disruption of the neuronal nitric oxide synthase gene
157. Neuronal nitric oxide synthase alternatively spliced forms: Prominent functional localizations in the brain
158. A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase
159. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle
160. Cloning of a novel neuronal nitric oxide synthase expressed in penis and lower urinary tract
161. Neuronal nitric oxide synthase isoforms alpha and mu are closely related calpain-sensitive proteins
162. Structural diversity of neuronal nitric oxide synthase mRNA in the nervous system
163. Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines
164. Regulation of neuronal nitric oxide synthase through alternative transcripts
165. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance
166. Alternative splicing of human inducible nitric-oxide synthase mRNA. Tissue-specific regulation and induction by cytokines
167. Cloning and characterization of human inducible nitric oxide synthase splice variants: A domain, encoded by exons 8 and 9, is critical for dimerization
168. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver
169. Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation?
170. Endothelial type nitric oxide synthase in skeletal muscle fibers: Mitochondrial relationships
171. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism
172. Production of nitric oxide by mitochondria
173. Nitric oxide synthase activity in mitochondria
174. Purification and characterization of a nitric oxide synthase from rat liver mitochondria
175. Cytoslic and membrane-bound nitric oxide synthase
176. Characterization of a microsomal calcium-dependent nitric oxide synthase in activated J774.2 monocyte/macrophages
177. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for up-regulated neuronal nitric oxide synthase
178. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis
179. Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage
180. 2+-dependent inducible nitric oxide synthase from guinea-pig lung
181. Induction of calcium-dependent nitric oxide synthases by sex hormones
182. High nitric oxide production in human paranasal sinuses
183. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity
184. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans
185. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?
186. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans
187. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
188. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse
189. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors
190. The influence of catabolic reactions on polyamine excretion
191. Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism
192. Inhibition of diamine oxidase promotes uptake of putrescine from rat small intestine
193. Aminoguanidine: A drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro
194. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis
195. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence
196. Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors
197. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
198. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase
199. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells
200. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors
201. 5-iminoethyl-L-ornithine
202. 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo
203. GW274150 is a potent, long-acting, highly-selective inhibitor of inducible nitric oxide synthase (NOS-2) with therapeutic potential in post-operative ileus
204. GW273629 is a highly-selective, short-acting iNOS (NOS-2) inhibitor both in vitro and in vivo: Beneficial effects in endotoxin shock
205. 6-(1-iminoethyl)lysine
206. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase
207. Anti-pterins as tools to characterize the function of tetrahydrobiopterin in NO synthase
208. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles
209. Nitric oxide synthase inhibitors with cardiovascular therapeutic potential
210. The inhibition of isoforms of nitric oxide synthase: Non-cardiovascular aspects
211. Design of isoform-selective inhibitors of nitric oxide synthase
212. Potent and selective-inhibition of human nitric-oxide synthases - Selective-inhibition of neuronal nitric-oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline
213. S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo
214. 5-(1-imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase
215. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats
216. ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia
217. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene
218. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats
219. 6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase
220. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon
221. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase
222. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)
223. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor
224. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin
225. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury
226. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice
227. Suppression of acute experimental colitis by an iNOS-selective inhibitor N-3-(aminomethyl)benzyl]acetamidine (1400W)
228. Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine
229. A microtiter-plate assay of human NOS isoforms